Y-Intercept (HK)’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,134
Closed -$128K 1743
2023
Q2
$128K Buy
+5,134
New +$150K 0.01% 1023

Other funds holding OMIC

Y-Intercept (HK)'s OMIC Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 5,134 shares — an estimated $128K sold.

Y-Intercept (HK) first reported a position in OMIC in Q2 2023 and held it in 1 quarter. The position peaked at $128K in Q2 2023. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

  • Y-Intercept (HK) reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 5,134 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $128K.
  • Y-Intercept (HK) first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Y-Intercept (HK)'s Singular Genomics Systems, Inc. Common Stock position peaked at $128K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.